Table of Contents

Executive Summary

ZX Market Snapshot: July 2022:

  • SpaceX, Stripe, Chainalysis were the three most active companies on ZX in July.
  • ZX received 315% more asks than bids in July marking the sixteenth consecutive month the order book has been skewed to the sell-side.
  • July transactions priced from a 67.6% premium to a 13.5% discount to May average reported holding values.

Reported Holdings: Three months ending May 31st, 2022

  • This quarter reporting holders marked down their private portfolios 8.1% with an average mark-down of 13.0%. The period saw more than four companies decline for each advancing company.
  • Sentiment up:
  • Sentiment down:

Heat Map: May 31st, 2022 Reporting Period

-8.1%

Appreciation/Depreciation of All Reported Holdings1

-13.0%

Average Mark-Up/Mark-Down Across All Reported Holdings2
Astera Labs
151.7%
Aledade
47.4%
BETA Technologies
40.8%
HaulHub
29.4%
ElevateBio
26.3%
SpaceX
25.0%
BYJU's
21.3%
Chime
15.7%
MOD Pizza
14.6%
Astranis
10.1%
SiMa ai
8.6%
Checkr
5.6%
Diamond Foundry
4.4%
AgBiome
2.3%
Aristea Therapeutics
1.6%
Epic Games
0.8%
PsiQuantum
0.1%
ABL Space
0.0%
Arctic Wolf
0.0%
Bombas
0.0%
Cava
0.0%
CelLink
0.0%
Celonis
0.0%
Color Genomics
0.0%
Convoy
0.0%
Discord
0.0%
Druva
0.0%
Enevate
0.0%
Fabletics
0.0%
Fanatics
0.0%
Goop
0.0%
Honor Tech
0.0%
Insitro
0.0%
Intarcia Therapeutics
0.0%
Magic Leap
0.0%
MNTN
0.0%
Nuro
0.0%
Omada Health
0.0%
Pine Labs
0.0%
Redwood Materials
0.0%
RefleXion Medical
0.0%
Resilience
0.0%
Savage X
0.0%
Seismic
0.0%
Skyryse
0.0%
Tempus Labs
0.0%
Thriveworks
0.0%
VideoAmp
0.0%
Waymo
0.0%
GupShup
-2.6%
Bolt
-4.3%
DNA Script
-4.3%
Relativity Space
-7.3%
Meesho
-8.5%
Bolt Threads
-8.8%
Rappi
-9.2%
Bytedance
-12.1%
Ant Financial
-13.2%
Farmers Business Network
-14.3%
Grammarly
-15.3%
Blink Health
-16.2%
Inscripta
-16.8%
Caris
-16.9%
Element Bio
-17.0%
Heal
-17.0%
Conformal Medical
-17.1%
ServiceTitan
-17.3%
Stripe
-17.3%
JUUL
-20.4%
FLEXE
-20.5%
Menlo Micro
-20.6%
Delhivery
-20.9%
GaN Systems
-20.9%
Freenome
-21.1%
Rapyd
-21.1%
Saluda Medical
-21.2%
Signifyd
-22.9%
Sonoma Bio
-23.5%
Ankyra
-23.7%
T-Knife
-23.7%
Deep Genomics
-23.8%
Evozyne
-23.8%
Generate Bio
-23.8%
Laronde
-23.8%
Skyhawk
-23.8%
Treeline Bio
-23.8%
ValenzaBio
-23.8%
Wugen
-23.8%
Boundless Bio
-24.2%
Sila Nano
-24.5%
Tenstorrent
-25.0%
Xsight Labs
-25.1%
SambaNova
-25.6%
Kardium
-25.8%
Faraday Pharma
-27.1%
Tipalti
-27.1%
FlixBus
-27.2%
Scorpion Therapeutics
-27.3%
dMed
-27.4%
Dragonfly Therapeutics
-27.4%
Quell
-27.4%
SalioGen
-27.5%
Tory Burch
-27.5%
Korro Bio
-27.8%
Unqork
-27.8%
Databricks
-29.5%
PrognomIQ
-30.7%
Verily
-32.4%
Asimov
-34.0%
Dataminr
-34.4%
Instacart
-38.2%
MasterClass
-40.2%
Reddit
-40.3%
Bowery
-41.0%
Rad Power
-42.2%
Algolia
-46.7%
goPuff
-50.5%
Castle Creek
-53.1%
D2iQ
-55.3%
Lime
-58.7%

1 Dollar-weighted return on all reported holdings
2 Equal-weighted mark-up or mark-down across all reported holdings

Analysis

Positive Trend Reversal3 (# = consecutive prior qtrs marked down or flat)
Negative Trend Reversal4 (# = consecutive prior qtrs marked up or flat)
Positive Trend Reversal3 (# = consecutive prior qtrs marked down or flat)
AgBiome
9
SpaceX
4
Aledade
3
ElevateBio
3
Negative Trend Reversal4 (# = consecutive prior qtrs marked up or flat)
MasterClass
7
Epic Games
6
Blink Health, Databricks
4
Rad Power, Reddit, Xsight Labs
4

3 Positive Trend Reversal reflects an individual holding marked up after consecutive quarterly periods marked down or flat
4 Negative Trend Reversal reflects an individual holding marked down after consecutive quarterly periods marked up or flat

Highest Variance in Reported Marks5
CompanyNormalized Std Dev5$ Weighted AvgMaxMin
Instacart.17$66.68$74.11$48.42
PsiQuantum.12$23.47$26.23$20.57
Ant Financial.11$1.70$2.85$1.63
Grammarly.10$22.21$26.21$20.97
JUUL.10$37.18$40.08$32.31

5 Normalized Standard Deviation is used to express the measure of spread across reported marks and allows for comparison between companies independent of their price per share based on a dollar-weighted average.

ZX Marketed Bids at Greatest Premium to Latest Reported Median Holding Value6
There were no Marketed bids at a premium this period
ZX Marketed Offers at Greatest Discount to Latest Reported Median Holding Value6
BYJU’s
-78.3%
Diamond Foundry
-53.7%
Bolt
-26.7%
Chime
-26.3%
Discord
-23.7%

6 Premium and Discount agnostic to share class

ZX Market Snapshot: July 2022

Most Active Companies7

1
arrow up
SpaceX
2
arrow up
Stripe
3
arrow up
Chainalysis
4
Epic Games
5
Arctic Wolf
6
arrow up
Klarna
7
arrow up
Databricks
8
arrow down
Flexport
9
arrow up
Airtable
10
arrow up
Addepar

7 Companies that received the most ticket and profile view activity over the last 30 days

SpaceX, Stripe and Chainalysis were the three most active companies on ZX in July.

ZX received 315% more asks than bids in July marking the sixteenth consecutive month the order book has been skewed to the sell-side. July transactions priced from a 67.6% premium to a 13.5% discount to May average reported holding values.

Reported Holdings Commentary: Three months ending May 31st, 2022

This quarter reporting holders marked down their private portfolios 8.1% with an average mark-down of 13.0%. The period saw more than four companies decline for each advancing company.

Astera Labs saw the largest mark-up this reporting period, with Aledade, BETA Technologies, and HaulHub rounding out the largest gainers.D2iQ saw the largest mark-down this reporting period, with goPuff, Algolia, and Rad Power rounding out the largest decliners.

AgBiome saw their first positive reversals in over two years while SpaceX saw their first positive reversal in one year. Meanwhile, MasterClass and Epic Games saw their first negative reversals in seven and six quarters, respectively.

This period, Instacart ($48.42 - $74.11) saw the highest share price variance across funds.

Disclaimer

This report is based on data reported by 200+ funds. Many holders of private company shares do not report their holding values and are thus not included in this report’s dataset. Further, many venture-backed private companies are not held by any reporting funds and are thus not included in this report. As such, this report should not be construed as providing a complete picture of shareholder sentiment or venture-backed private company performance. This report does not constitute investment advice or a "research report" as defined by FINRA Rules.

Zanbato, Inc. (“Zanbato”) prepares and disseminates market information about venture-backed private company securities, and the current bids and offers for those securities listed on the ATS operated by Zanbato (“ZX”). The information provided in this report has been prepared by sales, trading, or other non-research functions. Pricing indications and macro commentary are provided for factual information purposes only. This report is not intended to assess the individual merits of a particular investment or strategy, does not constitute a recommendation to buy or sell any financial instrument or to participate in any trading strategy and should not be construed as such. This report does not constitute investment advice. Certain information in this report has been obtained from third party sources and, while such information is believed by Zanbato to be reliable, it has not been independently verified by Zanbato and Zanbato shall not be responsible or liable, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with any use of, or reliance on, such third party information. Furthermore, the information contained in this report may not be current due to, among other things, changes in the financial markets or economic environment. Zanbato does not, and has no obligation to, update any such information contained in this report. Any prices or quotations contained herein are indicative only, do not represent firm quotes as to either price or size and should not be used for valuation purposes.

yukacon_arrow_up_right